newsbiomarker testingmetastatic non-small cell lung cancer
Systemic Treatment Remains Underused in Older Adults With Metastatic Non-Small Cell Lung Cancer
By MedXY|May 12, 2026
A large SEER-Medicare study found that fewer than half of older adults with metastatic NSCLC received systemic therapy, with only modest improvement from 2006 to 2021. Specialist referral and biomarker testing were strongly linked to treatm